Keyphrases
Valsartan
100%
Patients with Heart Failure
100%
Heart Failure Trials
100%
ACE Inhibitor Therapy
100%
Angiotensin-converting Enzyme Inhibitor (ACEi)
70%
Placebo
30%
Beta-blockers
20%
Heart Failure
10%
All-cause Mortality
10%
Quality of Life
10%
Sudden Death
10%
Heart Failure Hospitalization
10%
Resuscitation
10%
B-type Natriuretic Peptide
10%
Hospitalization
10%
Worsening Heart Failure
10%
Left Ventricular Remodeling
10%
Left Ventricular End-diastolic Diameter
10%
Aldosterone
10%
Beta-blockade
10%
Improved Ejection Fraction
10%
Parenteral Therapy
10%
Pharmacology, Toxicology and Pharmaceutical Science
Dipeptidyl Carboxypeptidase Inhibitor
100%
Congestive Heart Failure
100%
Valsartan
100%
Placebo
30%
Beta Adrenergic Receptor Blocking Agent
20%
All Cause Mortality
10%
Heart Ventricle Remodeling
10%
Noradrenalin
10%
Sudden Death
10%
Aldosterone
10%
Brain Natriuretic Peptide
10%